Beaird Harris Wealth Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Beaird Harris Wealth Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12	Closed	-$198	–	661
2023 Q4	$198	Hold	12	–	–	﹤0.01%	590
2023 Q3	$93	Hold	12	–	–	﹤0.01%	437
2023 Q2	$63	Hold	12	–	–	﹤0.01%	456
2023 Q1	$65	Hold	12	–	–	﹤0.01%	477
2022 Q4	$45	Hold	12	–	–	﹤0.01%	731
2022 Q3	$0	Buy	+12	New	+$67	﹤0.01%	543
2022 Q2	–	Sell	-12	Closed	–	–	654
2022 Q1	$0	Hold	12	–	–	﹤0.01%	757
2021 Q4	$0	Buy	+12	New	+$198	﹤0.01%	677

Beaird Harris Wealth Management's ORTX Position: Q1 2024 in Review

Beaird Harris Wealth Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 12 shares — an estimated $198 sold.

Beaird Harris Wealth Management first reported a position in ORTX in Q4 2021 and held it in 8 quarters. The position peaked at $198 in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Beaird Harris Wealth Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Beaird Harris Wealth Management sold 12 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $198.
Beaird Harris Wealth Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2021 and held it in 8 quarters.
Beaird Harris Wealth Management's Orchard Therapeutics plc American Depositary Shares position peaked at $198 in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Beaird Harris Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.